AntibodyLimited DatastaleRochePhase 2
QLS5132; Bevacizumab (QLS5132; Bevacizumab)
Gastric Cancer (GC); Non-small Cell Lung Cancer (NSCLC) · Gastric Cancer (GC)
#GastricCancerGC#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancerNSCLC+1
Trials 1Status Recruiting